What is Dr Nicholas DePace?
Franklin Cardiovascular, led by Dr. Nicholas L. DePace, M.D., F.A.C.C., operates as a premier medical practice dedicated to the intricate management of cardiovascular health and autonomic dysfunction. The organization distinguishes itself through a comprehensive approach to conditions such as Ehlers-Danlos Syndrome and Postural Orthostatic Tachycardia Syndrome (POTS). Beyond direct patient care, the firm provides high-level medical expert witness services and chronic care management, positioning itself as a thought leader in the intersection of cardiology and systemic autonomic health. Their commitment to non-invasive, holistic treatment modalities has established a unique market niche, particularly in the emerging field of long COVID recovery and complex chronic disease management.
How much funding has Dr Nicholas DePace raised?
Dr Nicholas DePace has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Dr Nicholas DePace
PPP
Public-Private Partnership
What's next for Dr Nicholas DePace?
With the recent infusion of capital, the organization is strategically positioned to scale its specialized treatment centers and enhance its research initiatives. The focus will likely shift toward broadening the accessibility of its proprietary treatment protocols for autonomic dysfunction while simultaneously scaling its medical expert witness division. As the healthcare landscape continues to prioritize specialized, patient-centric care, Dr Nicholas DePace is well-positioned to leverage this financial backing to solidify its status as a center of excellence for patients navigating the complexities of chronic cardiovascular and autonomic conditions.
See full Dr Nicholas DePace company page
